A genome-wide miRNA screen revealed miR-603 as a MGMT-regulating miRNA in glioblastomas-Reference-Cited by-同舟云学术

A genome-wide miRNA screen revealed miR-603 as a MGMT-regulating miRNA in glioblastomas

Published:2014-05-14 Issue:12 Volume:5 Page:4026-4039
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Kushwaha Deepa¹,Ramakrishnan Valya²,Ng Kimberly¹,Steed Tyler²,Nguyen Thien²,Futalan Diahnn²,Akers Johnny C.²,Sarkaria Jann³,Jiang Tao⁴,Chowdhury Dipanjan¹,Carter Bob S.²,Chen Clark C.²

Affiliation:

1. Dept. of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA

2. Center for Theoretical and Applied Neuro-Oncology, Moores Cancer Center, Division of Neurosurgery, University of California San Diego, San Diego, CA

3. Mayo Clinic, Department of Radiation Oncology, Rochester, MN

4. Department of Neurosurgery, Tiantan Medical Center, Beijing, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MGMT in TMZ-based glioma therapy: Multifaceted insights and clinical trial perspectives;Biochimica et Biophysica Acta (BBA) - Molecular Cell Research;2024-03

2. Temozolomide: a cytostatic drug that is still important today;Acta Poloniae Pharmaceutica - Drug Research;2023-03-03

3. Downregulation of DNMT3A Attenuates the Warburg Effect, Proliferation, and Invasion via Promoting the Inhibition of miR-603 on HK2 in Ovarian Cancer;Technology in Cancer Research & Treatment;2022-01

4. Elucidating the mechanisms of Temozolomide resistance in gliomas and the strategies to overcome the resistance.;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2021-12

5. Exosomal noncoding RNAs: key players in glioblastoma drug resistance;Molecular and Cellular Biochemistry;2021-07-17